Figure 2
Figure 2. MF CD34+ cells are more sensitive to the effects of LCP4. (A-E) Splenic MF and normal BM CD34+ cells were cultured in the presence of cytokines (50 ng/mL SCF + 100 ng/mL TPO) alone or cytokines plus LCP4 at doses ranging from 10 nM to 500 nM for 1 week. After treatment, cells were analyzed by mAb staining and flow cytometry. A proportion of cells generated in these cultures were also assayed in semi-solid media to assess the effect of LCP4 on MF and normal HPCs. The percentage of the total number of CD34+Lin− cells (A), CFU-MK (B), CFU-GM (C), as well as mature MKs (CD41a+CD34−CD15−) (D) and myeloid cells (CD15+CD34−CD41a−) (E), generated in the cultures exposed to cytokines plus LCP4 relative to those generated in the cultures exposed to cytokines alone is shown. *P < .05; **P < .01; ***P < .001; #P = .06; each dose of LCP4 vs 0 nM of LCP4 unless specified in the graphs. Splenic MF and N BM: n = 7 each. N BM, normal BM.

MF CD34+ cells are more sensitive to the effects of LCP4. (A-E) Splenic MF and normal BM CD34+ cells were cultured in the presence of cytokines (50 ng/mL SCF + 100 ng/mL TPO) alone or cytokines plus LCP4 at doses ranging from 10 nM to 500 nM for 1 week. After treatment, cells were analyzed by mAb staining and flow cytometry. A proportion of cells generated in these cultures were also assayed in semi-solid media to assess the effect of LCP4 on MF and normal HPCs. The percentage of the total number of CD34+Lin cells (A), CFU-MK (B), CFU-GM (C), as well as mature MKs (CD41a+CD34CD15) (D) and myeloid cells (CD15+CD34CD41a) (E), generated in the cultures exposed to cytokines plus LCP4 relative to those generated in the cultures exposed to cytokines alone is shown. *P < .05; **P < .01; ***P < .001; #P = .06; each dose of LCP4 vs 0 nM of LCP4 unless specified in the graphs. Splenic MF and N BM: n = 7 each. N BM, normal BM.

Close Modal

or Create an Account

Close Modal
Close Modal